Pulse Biosciences, Inc Common Stock (DE) (PLSE)
Pulse Biosciences, Inc. is a biotechnology company that develops innovative medical technologies based on its proprietary Nano-Pulse Stimulation (NPS) platform. The company focuses on creating minimally invasive, targeted treatments for a range of medical conditions, including dermatological and oncological applications. By utilizing high-frequency electrical pulses, Pulse Biosciences aims to provide precise and effective therapies with reduced patient recovery times.
Company News
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. (NYSE: PVH) to report quarterly earnings at $3.52 per share on revenue of $2.42 billion after the closing bell, according to data from Benzinga Pro. PVH shares gained 0.3% to $141.00 in after-hours trading. Oxford Industries, Inc. (NYSE: OXM) reported downbeat financial results ...
Hot penny stocks to add to your watch list this week. Is it time to buy? The post Hot Penny Stocks To Watch As The Stock Market Crash Continues appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The medical technology company got rid of $41.6 million in debt with a large private sale of stock on Thursday.